Chemeq names new CEO
Tuesday, 26 July, 2005
Antimicrobial specialist Chemeq (ASX:CMQ) has named David Williams its new CEO and director, commencing August 1. Williams was formerly CEO of Epic Energy, a gas transmission company.
Chemeq's founder scientist, Graham Melrose, will remain executive chairman until a new chairman is appointed.
The company also announced that it has banked AUD$20 million after the allotment of 20,000 convertible bonds with a face value of $1000 each to Mizuho International, Stark Trading and Shepherd Investments. An aggregate additional subscription fee of $350,000 has been paid to the three companies.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
